Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,565 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial.
Franek E, Pais P, Basile J, Nicolay C, Raha S, Hickey A, Ahmad NN, Konig M, Kan H, Gerstein HC. Franek E, et al. Among authors: kan h. Cardiovasc Diabetol. 2023 Mar 10;22(1):52. doi: 10.1186/s12933-023-01757-z. Cardiovasc Diabetol. 2023. PMID: 36899386 Free PMC article. Clinical Trial.
Real-world primary nonadherence to antiobesity medications.
Kan H, Bae JP, Dunn JP, Buysman EK, Gronroos NN, Swindle JP, Bengtson LGS, Ahmad N. Kan H, et al. J Manag Care Spec Pharm. 2023 Oct;29(10):1099-1108. doi: 10.18553/jmcp.2023.23083. Epub 2023 Aug 18. J Manag Care Spec Pharm. 2023. PMID: 37594848 Free PMC article.
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.
Hankosky ER, Wang H, Neff LM, Kan H, Wang F, Ahmad NN, Griffin R, Stefanski A, Garvey WT. Hankosky ER, et al. Among authors: kan h. Diabetes Obes Metab. 2024 Jan;26(1):319-328. doi: 10.1111/dom.15318. Epub 2023 Nov 6. Diabetes Obes Metab. 2024. PMID: 37932236 Clinical Trial.
Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making.
Gudzune KA, Kaplan LM, Kahan S, Kumar RB, Dunn JP, Ahmad NN, Poon JL, Sims TJ, Mackie DS, Jauregui AK, Balkaran BL, Kan H, Ard J; OBSERVE study. Gudzune KA, et al. Among authors: kan h. Endocr Pract. 2024 Oct;30(10):917-926. doi: 10.1016/j.eprac.2024.06.009. Epub 2024 Jun 18. Endocr Pract. 2024. PMID: 38901731 Free article.
1,565 results